[ LOGINCONTACT USHOME ]   

WORKS IN PROGRESS DEADLINE: JULY 18, 2008

Click here for guidelines

Title

First Author
Name Degree
Institution
Postal Address
Phone Number
Fax Number
E-mail Addres

Secondary Authors
1 Name Institution
  City State
2 Name Institution
  City State
3 Name Institution
  City State
4 Name Institution
  City State
5 Name Institution
  City State

Abstract Text. Please limit your abstract to 200 words.

Description of the abstract indicating its significance, timeliness, and describing why it could not have been submitted for the April 4, 2008, deadline.

ABSTRACT AUTHORS’ ACKNOWLEDGEMENT, CONCURRENCE AND DISCLOSURE STATEMENT

The authors have read and agreed with the content of this abstract submitted to the 133rd Annual Meeting of the ANA. Acknowledged is all support for studies relating to the abstract. If, within the past year, an author or immediate family member has had a substantial personal financial relationship relating to the support of the abstract, this relationship must be described briefly. Such relationships include salaries, ownership, equity positions, stock options, royalties, consulting fees and honoraria for speaking, material support, and other financial arrangements. All sources of funding support, including public, for the work described will be published with the abstract in the Program Supplement of Annals of Neurology. If accepted, it is understood that this materials has not been nor will be presented elsewhere prior to the meeting.

The authors have read and agree with the above Abstract Authors’ Acknowledgement, Concurrence and Disclosure Statement.

This study has has not been supported. If supported, indicate by whom:



The authors do do not have a substantial personal financial relationship as described in the Abstract Authors’ Acknowledgement, Concurrence and Disclosure Statement. If a relationship exists, briefly describe:



©2008 American Neurological Association. All rights reserved.
eBusiness solutions provided by Rare Earth Interactive